A prototype of ultrasensitive time-resolved fluoroimmunoassay for the quantitation of lead in plasma using a fluorescence-enhanced europium chelate label for the detection system

Ibrahim A. Darwish,Kenzi Suzuki,Hiroshi Ogawa,Zongzhi Wang
DOI: https://doi.org/10.1039/d3ra07673c
IF: 4.036
2024-01-01
RSC Advances
Abstract:This study describes the development and validation of a prototype time-resolved fluoroimmunoassay (TRFIA) for the quantification of lead in plasma. The assay is valuable for controlling the exposure of humans to potential lead toxicities.
chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper aims to develop an ultra-sensitive time-resolved fluorescence immunoassay (TRFIA) prototype for detecting lead (Pb) concentrations in plasma. The study employed a competitive binding format on a 96-well microplate, utilizing a mouse monoclonal antibody 2C33 that recognizes lead diethylenetriamine pentaacetate (Pb-DTPA) but not the lead-free DTPA chelator. By treating the samples with an excess of DTPA to form Pb-DTPA chelates, these chelates compete with Pb-DTPA-bovine serum albumin (BSA) coated on the inner surface of the detection plate wells for the limited binding sites of the 2C33 antibody. Europium-DTPA labeled secondary antibodies and a fluorescence enhancement solution are used to quantify the formed antigen-antibody complexes. The TRFIA was optimized and validated, with a working range of 20 to 300 pg/mL and a quantification limit of 20 pg/mL. Metals commonly found in plasma do not interfere with the proposed TRFIA for lead analysis. The method was applied to the quantification of lead in plasma samples, demonstrating satisfactory accuracy and precision, with results comparable to those obtained by atomic emission spectroscopy. This study represents the first TRFIA for the quantification of lead in plasma, offering advantages in sensitivity, convenience, and analytical throughput compared to existing atomic spectroscopy methods and other lead immunoassays, and holds promise for effectively assessing lead concentrations and controlling human exposure to its potential toxicity. Furthermore, the paper highlights the health impacts of global lead contamination and the high susceptibility and vulnerability of children to lead poisoning, underscoring the importance of developing such ultra-sensitive detection technologies.